Sjóvá – Fjárfestakynning vegna 4. ársfjórðungs og ársuppgjörs 2020
Í viðhengi er fjárfestakynning á uppgjöri Sjóvá-Almennra trygginga hf. vegna 4. ársfjórðungs og ársuppgjörs fyrir árið 2020.ViðhengiSjóvá – Fjárfestakynning 4F 2020 og ársins
Month: February 2021
Connectyx Announces Key Biotech Industry Veterans to Management Team
Expertise in Clinical Development, Regulatory Affairs and Manufacturing RepresentedBoca Raton, Fla, Feb. 11, 2021 (GLOBE NEWSWIRE) — Connectyx Technologies Holdings Group, Inc. (OTC: CTYX) (“Connectyx” or the “Company”), Connectyx announced today the addition of three industry veterans to the company’s management team. I Richard Garr will be joining the Company as chief executive officer and general counsel, Ron Bordens Ph.D. has been named executive vice president of technical operations and manufacturing, and Michael Grace Ph.D. has agreed to become chairman of the scientific advisory board. Paul M. Michaels will continue as executive chairman and president of Connectyx; and Dr. Barry Ginsberg will continue as vice chairman and chief strategy officer.Chairman Michaels noted, “When I began the journey as interim chief executive...
Eik fasteignafélag hf.: Management results 2020 and financial budget 2021
According to management results EBITDA for the year amounted to ISK 5,038 million which is in line with management’s updated forecast which was announced on Nasdaq in June 2020.Key results:Income from operations amounted to ISK 8,345 million.Rental income amounted to ISK 7,562 million and increased by 2% between years.EBITDA amounted to ISK 5,038 million.Changes in fair value of investment properties amounted to ISK 594 million.Net cash from operating activities amounted to ISK 1,858 million.Book value of the Company’s properties amounted to ISK 100,316 million.Interest bearing debt amounted to ISK 62,001 million.Weighted indexed interest rates were 3.15%Weighted unindexed interest rates were 2.91%Equity ratio was 31.3%.The Company’s economic occupancy ratio was 92.0% at the end of the year.Financial budget 2021:Due to continuing uncertainty...
AngioSoma and its Subsidiary SomaCeuticals Announce Amended and Restated Execution of Global License for Multiple Sclerosis Patent
Houston, TX, Feb. 11, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — AngioSoma Inc. (OTC: SOAN) (“AngioSoma” or the “Company”), through its wholly-owned subsidiary, SomaCeuticals, Inc., is pleased to announce that the Exclusive Global Multiple Sclerosis License Agreement dated August 23, 2020 has been amended and restated as of February 4, 2021 to give both parties a stronger and more robust platform to move synergistically forward to market and license Patent 10,619,592 issued to Fabrizio de Silvestri as inventor.Fabrizio de Silvestri stated, “It is wonderful that Jim Katzaroff and his group are actively interviewing Contract Research Organizations as well as possible funding sources. This looks to be a very exciting and critical year for AngioSoma.”“I am so delighted that Jim was able to complete this transaction in a...
Eik fasteignafélag hf.: Stjórnendauppgjör 2020 og fjárhagsáætlun 2021
Samkvæmt stjórnendauppgjöri nam EBITDA ársins 5.038 m.kr. og eru niðurstöðurnar í takt við uppfærðar horfur félagsins sem birtar voru í kauphöll í júní 2020.Helstu niðurstöður eru:Rekstrartekjur námu 8.345 m.kr.Leigutekjur námu 7.562 m.kr. og jukust um 2% milli áraRekstrarhagnaður fyrir matsbreytingu, söluhagnað fjárfestingareigna og afskriftir nam 5.038 m.kr.Matsbreyting fjárfestingareigna nam 594 m.kr.Handbært fé frá rekstri nam 1.858 m.kr.Bókfært virði fasteigna nam 100.316 m.kr.Vaxtaberandi skuldir námu 62.001 m.kr.Vegnir verðtryggðir vextir námu 3,15%Vegnir óverðtryggðir vextir námu 2,91%Eiginfjárhlutfall nam 31,3% í lok ársVirðisútleiguhlutfall nam 92,0% í lok ársFjárhagsáætlun 2021:Vegna áframhaldandi óvissu um áhrif COVID-19 á rekstur félagsins birtir félagið spá um EBITDA fyrir árið 2021 í stað spár um tekjur og gjöld. Jafnframt...
Resolutions of the Extraordinary Meeting of AB „Snaigė“ shareholders
The Extraordinary General Meeting of shareholders of Snaige AB (further – the Company) was held on 11 February 2021. Decisions on the agenda questions were adopted on the Extraordinary General Meeting.1. The agenda question: Delisting of shares of the Company from trading on the regulated market AB Nasdaq Vilnius and non-execution of public offering of shares of the CompanyThe decision:“1.1. To initiate delisting of all the outstanding shares of the Company and to delist them from trading on the regulated market AB Nasdaq Vilnius as well as not to continue the public offering thereof.1.2. To establish that the Company’s shareholders, who voted “for” the decision to delist the shares of the Company from trading on the regulated market AB Nasdaq Vilnius and not to continue the public offering of shares of the Company, will under the procedure...
AB „Snaigė“ neeilinio visuotinio akcininkų susirinkimo sprendimai
2021 m. vasario 11 d. įvyko neeilinis visuotinis AB „Snaigė“ (toliau – Bendrovė) akcininkų susirinkimas.Susirinkime buvo priimti šie sprendimai darbotvarkės klausimais.1 darbotvarkės klausimas: Bendrovės akcijų išbraukimas iš prekybos reguliuojamoje rinkoje AB Nasdaq Vilnius ir Bendrovės akcijų viešo siūlymo nebevykdymasSprendimas„1.1. Inicijuoti visų Bendrovės išleistų akcijų išbraukimą ir išbraukti jas iš prekybos reguliuojamoje rinkoje AB Nasdaq Vilnius bei nebesiūlyti jų viešai.1.2. Nustatyti, kad Bendrovės akcininkai, balsavę „už“ sprendimą išbraukti Bendrovės akcijas iš prekybos reguliuojamoje rinkoje AB Nasdaq Vilnius ir nebesiūlyti Bendrovės akcijų viešai, taikytinų teisės aktų nustatyta tvarka pateiks Lietuvos bankui oficialaus siūlymo, kuriuo siekiama išbraukti Bendrovės akcijas iš prekybos AB Nasdaq Vilnius, cirkuliarą tvirtinimui...
Sjóvá-Almennar tryggingar hf. – Ársuppgjör 2020
Í viðhengi er fréttatilkynning Sjóvá um afkomu 4. ársfjórðungs 2020 og ársins í heild, svo og ársreikningur samstæðunnar fyrir árið 2020.ViðhengiSjóvá – Fréttatilkynning 4F 2020 og ársinsSjóvá – Ársreikningur samstæðunnar 2020
WeedMD Inc. Announces Increase in Bought Deal Equity Financing to $17.5 Million
Not for distribution in the U.S. or to U.S. newswire servicesTORONTO, Feb. 11, 2021 (GLOBE NEWSWIRE) — WeedMD Inc. (“WeedMD” or the “Company”) (TSX-V:WMD) (OTCQX:WDDMF) (FSE:4WE), a federally-licensed producer and distributor of medical-grade cannabis, is pleased to announce that it has entered into an amended letter of engagement with Eight Capital, under which Eight Capital has now agreed to purchase, as joint bookrunner and co-lead underwriter along with Canaccord Genuity Corp. (the “Co-Lead Underwriters”), 21,342,000 units of the Company (the “Units”), on a “bought deal” basis pursuant to a filing of a short form prospectus, subject to all required regulatory approvals, at a price per Unit of $0.82 (the “Issue Price”) for gross proceeds of $17,500,440 (the “Offering”).The Company has agreed to grant Eight Capital an over-allotment...
BASF advances renewable energy commitment with wind and solar power contracts
Wind power agreement at two Texas sites will add 35 MW to BASF’s renewable energy supply; solar power at 55MW is the ‘cherry on top’Up to 90% of the sites’ purchased power from wind and solar farmsFREEPORT, Texas, Feb. 11, 2021 (GLOBE NEWSWIRE) — BASF is collaborating with EDF Energy North America to improve the energy balance and reduce CO2 emissions of two of its production sites in Texas. The companies have signed a 35 MW Wind Power Purchase Agreement (PPA) that will bring 25 MW wind power to BASF’s Verbund site in Freeport and 10 MW wind power to the Pasadena site. The agreement adds to another recently announced PPA that will supply the Freeport site with 55 MW power from EDF Renewables’ Space City Solar project.“The agreements underline BASF’s commitment to sustainability. Manufacturing products for sustainable solutions,...
